We need a new paradigm for addiction that puts psychology first and recognizes its heterogeneity. Only then will we see that ...

Real-world adverse events are rarely monocausal. They emerge from the interaction of drug exposure, comorbid conditions, physiological states, concomitant medications, and patient-specific ...

Bacterial Conjunctivitis Drugs Market is expected to reach US$ 4.9 Billion by 2036, Driven by Increasing Prevalence of Eye ...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want ...

Learn about Agentic AI and its role in enhancing decision-making in drug discovery through planned actions and verified ...

For years, we've thought of autism as lying on a spectrum, but emerging evidence suggests that it comes in several distinct ...

Epithelioma Treatment Market to reach USD 13.1 billion by 2035, driven by rising skin cancer cases and growing adoption of ...

Discover why the 'Mother of All Sciences' in 2026 is mathematics. Discover its significance in AI, high-energy physics, and ...

Mongolian shamans beat wicker drums to summon ancestral spirits. A Peruvian man in a headdress unleashes a piercing ululation ...

CellVoyant, an AI-first biotech based in Bristol UK,  today launches FateView™, the first online predictive cell analytics platform designed to help cell-based therapeutic drug developers reduce costs ...

This empirical study demonstrates that a multi-criteria decision analysis (MCDA) framework is a feasible and consistent supplementary tool for evaluating the value of orphan medicinal products (OMPs) ...

Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed ...